InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Perros Manoussos, Chairman & CEO. Officer active across 1 company, notably Entasis Therapeutics Holdings Inc.. Aggregated, 6 disclosures have been recorded. Activity tracked since 19 October 2021. The latest transaction was disclosed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
125,000 shares0Common StockSEC:0001104659-22-005423
125,000 shares0Common StockSEC:0001104659-22-005423:0
11,704 shares@ US$2.9450.0% of flowCommon StockSEC:0001104659-21-133627:0
11,704 shares@ US$2.94100.0% of flowCommon StockSEC:0001104659-21-133627
79,750 shares0Common StockSEC:0001104659-21-128067
79,750 shares0Common StockSEC:0001104659-21-128067:0
6 of 6 declarations
About Perros Manoussos
Manoussos Perros is the Chief Executive Officer of Entasis Therapeutics Holdings Inc. He leads the company's operations, focused on developing innovative treatments. His leadership is crucial to the company's mission in the pharmaceutical sector.
